https://www.nature.com/articles/s41375-022-01713-y
0
0
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial | Leukemia - Nature.com
10/14/22 at 7:52pm
Organization
Nature.com
Authors
Details
54 words
Summarize
Cancer FDG-PET analysis PETAL non-Hodgkin lymphoma Leukemia - Nature.com Leukemia
Leukemia - Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial
Create an account or login to join the discussion